Cancer is the leading cause of death for HIV-infected persons in economically developed
countries, even in the era of antiretroviral therapy (ART). Lymphomas remain a leading …

Not long after the recognition of HIV as the causative agent of AIDS, it was evident that
individuals infected with HIV developed lymphoma at a greater rate than the population at …

Purpose Despite advances in the treatment of HIV, HIV-infected people remain at increased
risk for many cancers, and the number of non–AIDS-defining cancers is increasing with the …

This book grew out of a scientific review, originally published in Microbiological Reviews. It
has been updated and expanded-now citing more than 2100 references (100 pages of the …

The outcome of acquired immunodeficiency syndrome–related lymphomas (ARLs) has
improved since the era of highly active antiretroviral therapy, but median survival remains …

Purpose: To describe the clinical features and outcome of HIV-associated primary effusion
lymphoma (PEL) and to compare them with those of the other HIV-associated non-Hodgkin's …

Antiretroviral therapy (ART) shows variable blood-brain barrier penetration. This may affect
the development of neurological complications of HIV infection. In attempts to attenuate viral …

Purpose To compare outcomes of patients with HIV-Burkitt's lymphoma (HIV-BL) and HIV-
diffuse large-cell lymphoma (HIV-DLCL) after treatment with CHOP (cyclophosphamide …

Background Plasmablastic lymphoma (PBL) has been described as a rapidly progressive
and almost invariably fatal CD20–VS38c+ diffuse large-cell lymphoma with plasmablastic …

Evidence suggests that infusional therapy is a more effective means for administering
cytotoxic therapy than intravenous bolus therapy for lymphoma and offers greater potential …